Novartis Pharmaceuticals Corporation v. Lupin Atlantis Holdings, S.A. et al
| Novartis Pharmaceuticals Corporation |
| Lupin Pharmaceuticals, Inc., Lupin Limited, Lupin Atlantis Holdings, S.A. and Lupin Inc. |
| 1:2021cv00229 |
| February 18, 2021 |
| US District Court for the District of Delaware |
| Leonard P Stark |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 1, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 9 WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Lupin Pharmaceuticals, Inc. waiver sent on 2/25/2021, answer due 4/26/2021. (Joyce, Alexandra) |
| Filing 8 WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Lupin Limited waiver sent on 2/25/2021, answer due 4/26/2021. (Joyce, Alexandra) |
| Filing 7 WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Lupin Inc. waiver sent on 2/25/2021, answer due 4/26/2021. (Joyce, Alexandra) |
| Filing 6 WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Lupin Atlantis Holdings, S.A. waiver sent on 2/25/2021, answer due 4/26/2021. (Joyce, Alexandra) |
| Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (apk) |
| Filing 4 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/5/2021. Date of Expiration of Patent: SEE ANDA FORM.Thirty Month Stay Deadline: 7/7/2023. (apk) |
| Filing 3 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,101,659 ;8,796,331 ;8,877,938 ;9,388,134. (apk) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) |
| Filing 1 COMPLAINT filed against Lupin Atlantis Holdings, S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3530964.) - filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A-D, #2 Civil Cover Sheet)(apk) |
| No Summons Issued. (apk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
